Risks for MDS/Leukemia Increased for Survivors of Common Lymphoid Neoplasms
THURSDAY, Aug. 17, 2023 -- Survivors of common lymphoid neoplasms (LNs) have increased risks for therapy-related myelodysplastic syndrome/acute myeloid leukemia (tMDS/AML), although risks have been lower in more recent years, according to a study...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Acute Leukemia | Acute Myeloid Leukemia | Leukemia | Myelodysplastic Syndrome | Pharmaceuticals | Study